111In-DTPA-Octreotide SPECT (OctreoScan) uptake in metastatic renal cell carcinoma to the pancreas
We report a case of late presentation of metastatic renal cell carcinoma (RCC) demonstrating intense 111In-DTPA-octreotide uptake in pancreas without recurrence at the primary site. Immunohistochemistry study revealed somatostatin receptor subtype 2 of metastatic RCC preferentially expressed on tumo...
Main Authors: | Chan, K, Luong, T, Navalkissoor, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Lippincott, Williams & Wilkins
2018
|
Similar Items
-
Whole body diffusion for metastatic disease assessment in neuroendocrine carcinomas: comparison with OctreoScan® in two cases
by: Cossetti Rachel Jorge D, et al.
Published: (2012-05-01) -
Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET: Evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT
by: Schreiter Nils Friedemann, et al.
Published: (2014-12-01) -
In-111 octreotide SPECT/CT in the early diagnosis of pulmonary sarcoidosis: A case report
by: Roberto G. Carbone, MD, et al.
Published: (2022-02-01) -
Evaluation of reconstruction methods and image noise levels concerning visual assessment of simulated liver lesions in 111In-octreotide SPECT imaging
by: Emma Wikberg, et al.
Published: (2023-06-01) -
Radiosynthesis and Animal Studies of 111In-DTPA-bis-alendronate Complex
by: Ashraf Fakhari, et al.
Published: (2015-09-01)